Healthcare
NBGI's Praticdose to merge with Cima
NBGI Private Equity has completed the bolt-on acquisition of French healthcare equipment provider Cima, which will be merged with Praticdose.
Seventure's Biophytis secures €2m B-round funding
Seventure Partners and CM-CIC Capital Privé have joined new investor Metabrain Research in a €2m series-B financing round for French pharmaceuticals company Biophytis.
Seventure's Biophytis secures €2m B-round funding
Seventure Partners and CM-CIC Capital Privé have joined new investor Metabrain Research in a €2m series-B financing round for French pharmaceuticals company Biophytis.
YFM in £3m round for ImmunoBiology
YFM Equity Partners has contributed ТЃ900,000 as part of a ТЃ3m funding round for Cambridge-based biotech firm ImmunoBiology.
Apax's Mann leaves, replaced by healthcare co-head
Senior healthcare deal-maker Khawar Mann has left Apax Partners to join Russian clinics group Medsi.
Asclepios backs Genmedica with €12m
Life sciences-focused VC Asclepios Bioresearch has invested €12m in Spanish biotech firm Genmedica Therapeutics.
August Equity appoints investment director
UK-based private equity house August Equity has hired Stuart Quin as an investment director to focus primarily on the healthcare sector.
AXA PE buys Limacorporate stake
AXA Private Equity and banking group Intesa Sanpaolo have acquired a 66% stake in orthopaedic devices producer Limacorporate.
Advent to take Mediq private for €775m
Advent International has announced plans to delist Dutch pharma company Mediq from the Euronext Amsterdam, valuing the company at €775m.
Spark backs Molplex with £350,000
Spark Impact has invested ТЃ350,000 into drug discovery company Molplex.
Wellington Partners IV holds €70m first close
Wellington Partners has held a first closing for Wellington Partners IV Life Science on €70m.
Medical technology: Healthcare's third way
In between the hotly sought after healthcare services market and the much watched pharmaceuticals niche sits an elusive sub-sector. What has become of the UK medical technology and supplies sector?
Inveready in €1m round for AB Therapeutics
Inveready has taken part in a €1m funding round for Spanish pharmaceuticals firm AB Therapeutics.
Spanish VCs back ForMune with €4.4m
Venture capital firms Inveready and Caja Navarra, alongside public company Navarra Development Society (Sodena), have supported the spinout of biotech firm ForMune from parent company Digna Biotech with a capital commitment of €4.4m over the next three...
Sovereign's City & County in 10th acquisition
Sovereign Capital-backed City & County Healthcare Group has acquired Conard Care Services, a Northern Irish domiciliary care provider, in its 10th bolt-on since 2009.
SV Life Sciences et al. in $7.6m series-B for Karus
Karus Therapeutics has secured a $7.6m series-B financing round, led by SV Life Sciences, New Leaf Ventures, Novo A/S and International Biotechnology Trust.
Innova Capital backs Ujastek Hospital
Innova Capital has invested in Poland-based Ujastek Obstetrics and Gynaecological Hospital.
Peppermint et al. invest in IOP
Peppermint Venture Partners, Enjoy Venture and KFW's ERP Startfonds have invested €1.6m in German eye disease monitoring company Implandata Ophthalmic Products (IOP), completing its series-A funding round.
Sovereign's Christchurch Group makes acquisition
Sovereign Capital portfolio company Christchurch Group has acquired Woodlands Respite Care Centre from the MS Society.
I2C backs Keramat with €600,000
Government-backed Galician venture capital fund I2C has injected €600,000 into ceramic biomaterials firm Keramat.
Investor consortium sells Sirigen to BD
Seraphim Capital, Oxford Capital Partners, Nesta, IQ Capital and YFM Equity Partners have sold high sensitivity fluorescence manufacturer Sirigen Group Ltd to US trade player Becton Dickinson and Company (BD).
AXA PE acquires Riemser from TVM
AXA Private Equity has acquired a majority stake in German speciality pharmaceuticals company Riemser Arzneimittel from the company's founding family and minority investors, including TVM Capital.
Cinven acquires Mercury Pharma from HgCapital
Cinven has acquired UK-based speciality pharmaceutical company Mercury Pharma in a ТЃ465m secondary buyout from HgCapital.
Bridgepoint-backed Care UK makes acquisition
Bridgepoint-backed Care UK has acquired residential care provider Whitwood Care from family-owned Michael Wheatley Holdings.